Genetic & Genomic MedicineNeurologyPeer-reviewed
Transcription factor binding and individual genetic risk for valproate teratogenicity
Alison Anderson, Piero Perucca, Elena Vianca…·Sameer M. Zuberi
The paper investigates how genetic variants affecting transcription factor binding contribute to valproate-induced birth defects and identifies EP300 as a key regulator involved in this process.
3 citationstop 1%